NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Tamoxifen Citrate


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data on life sciences described by D.A. Adamopoulos et al
2009 MAR 23 ... Greece report. "This sample included IO men (n=106) treated with tamoxifen citrate (10 mg b.i.d.) and testosterone undecanoate (40 mg t.i.d.) or placebo (n=106) and ...
Subject: Life Sciences
Price: $3.00
*
Federal Trade Commission Files Complaint Against Par Pharmaceutical Over Court-Approved AndroGel(R) Litigation Settlement
2009 FEB 16 ... numerous federal circuit and district courts, including by the Second Circuit in In re Tamoxifen Citrate Antitrust Litigation, 466 F.3d 187 (2d Cir. 2006), and by the Federal Circuit in In re ...
Subject: Patents
Price: $3.00
*
Research on relapsing polychondritis discussed by scientists at Thomas Jefferson University
2009 MAR 9 ... lesion did not meliorate the disease process, but a recent encouraging response to tamoxifen citrate has been observed with improvements in vocal fold motion and activity levels. Prognosis ...
Subject: Relapsing Polychondritis
Price: $3.00
*
Barr Pharmaceuticals, Inc., officials provide details on the latest developments
2007 AUG 20 ... petitions for review of the Second Circuit's decision in Barr's favor in the Tamoxifen Citrate antitrust lawsuits. The Court's ruling ends the antitrust litigation over the 1993 ...
Subject: Barr Pharmaceuticals, Inc.
Price: $3.00
*
Barr Pharmaceuticals, Inc., reports on new developments
2007 SEP 11 ... petitions for review of the Second Circuit's decision in Barr's favor in the Tamoxifen Citrate antitrust lawsuits. The Court's ruling ends the antitrust litigation over the 1993 ...
Subject: Barr Pharmaceuticals, Inc.
Price: $3.00
*
Cytogen Reports Third Quarter 2007 Financial Results
2007 NOV 19 ... approximately $1.8 million associated with assets related to its product, SOLTAMOX(TM) (tamoxifen citrate). "Over recent months, Cytogen has continued implementing a number of ...
Subject: Biotechnology Business
Price: $3.00
*
Data from T.L. Horn et al provide new insights into breast cancer
2007 DEC 24 ... "The present study was conducted to support the preclinical development of TAM (tamoxifen citrate) 1 BEX for use in breast cancer chemoprevention, and to investigate the influence of ...
Subject: Breast Cancer
Price: $3.00
*
Data on life sciences described by researchers at Medical College of Ohio, Department of Urology
2008 MAR 17 ... earlier reported that administration of cyproterone acetate, fluphenazine decanoate, tamoxifen citrate, oestradiol valerate to adult male rats, at doses of 50, 5.77, 0.71, 0.28 micromol ...
Subject: Life Sciences
Price: $3.00
*
New breast cancer therapy research reported from University of Louisville, Department of Surgery
2007 AUG 13 ... diagnosis is unclear. BMI was calculated for patients in the North American Fareston and Tamoxifen Adjuvant trial, and was correlated with clinicopathologic factors, including stage at ... Carcinoma, Drugs, Fareston, Oncology, Pharmaceuticals, Tamoxifen, Therapy, Toremifene Citrate, Treatment, Women's Health. This article was prepared by Biotech ...
Subject: Breast Cancer Therapy
Price: $3.00
*
New radiation therapy study findings have been reported by scientists at University of Louisville, Department of Surgery
2008 JUN 30 ... use RT in this setting." "Patients in the North American Fareston vs. Tamoxifen Adjuvant (NAFTA) trial who had BCS were evaluated for factors influencing the use of RT ... Fareston, Oncology, Pharmaceuticals, Radiation Therapy, Surgery, Tamoxifen, Toremifene Citrate, Treatment, Women's Health. This article was prepared by Biotech ...
Subject: Radiation Therapy
Price: $3.00
*
New research from University of Lisbon, Portugal, described
2007 AUG 14 ... ablation -21; percutaneous ethanol injection -29; transarterial chemoembolization -49; tamoxifen -49; supportive care alone -53," explained A. Martins and colleagues, University of ... were the most frequent dispensed medicines (51.3%). In relation to paediatrics, Caffeine Citrate for primary apnoea of premature newborns had the higher frequency distribution (57.1%). ...
Subject: University of Lisbon, Portugal
Price: $3.00
*
Officials from Cytogen Corporation recently report on new developments
2007 AUG 20 ... opportunities with the in-licensing of two marketed therapeutic products, SOLTAMOX(TM) (tamoxifen citrate) and CAPHOSOL, which firmly established Cytogen as a product-focused company with a ...
Subject: Cytogen Corporation
Price: $3.00
*
Officials from Cytogen Corporation report on recent activities
2007 SEP 11 ... first quarter 2007 results do not include revenues from CAPHOSOL(R) and SOLTAMOX(TM) (tamoxifen citrate), which were introduced in March 2007 and August 2006, respectively. In accordance with ...
Subject: Cytogen Corporation
Price: $3.00
*
Reports from University of Texas, M. D. Anderson Cancer Center add new data to research in breast cancer clinical trial
2008 MAR 17 ... Hormones, Hot Flash, Hot Flashes, Nolvadex, Oncology, Pharmaceuticals, Tamoxifen, Tamoxifen Citrate, Therapy, Treatment, Women's Health. This article was prepared by ...
Subject: Breast Cancer Clinical Trial
Price: $3.00
*
Reports outline life sciences research from Kobe Pharmaceutical University, Department of Pharmaceutical Technology
2008 MAY 19 ... and an anhydrous form would exist during heating. The physicochemical stability of tamoxifen citrate forms A and B suspended in water and of form A during kneading and drying suggested that ...
Subject: Life Sciences
Price: $3.00
*
Research from McGill University provide new insights into female infertility
2007 AUG 27 ... Research, Gonadotropin, Gynecology, Infertility, Letrozole, Obstetrics, Pharmaceuticals, Tamoxifen, Therapy, Treatment, McGill University. This article was prepared by ... in ovulation induction. Recent findings Aromatase inhibitors can replace clomiphene citrate as ovulation-inducing substances," scientists in Montreal, Canada report. ...
Subject: Female Infertility
Price: $3.00
*
Scientists at University of Iowa publish new data on life sciences
2008 JUL 14 ... settlements in the wake of the Medicare Modernization Act of 2003 and In re Tamoxifen Citrate Litigation. Iowa Law Review, 2008;93(3):1015-1065). For additional ...
Subject: Life Sciences
Price: $3.00
*
Study results from Dokuz Eylul University provide new insights into bipolar disorder
2008 APR 14 ... To perform a controlled test of antimanic efficacy of the centrally active PKC inhibitor tamoxifen citrate." "Three-week, randomized, double-blind, placebo-controlled, ...
Subject: Bipolar Disorder
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login